title: Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.
abstract: Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting.
authors.affiliation: Royal Brompton Hospital, Sydney Street, SW3 6NP London, U.K. d.macrae@rbh.nthames.nhs.uk
authors.forename: Duncan J
authors.initials: DJ
authors.lastname: Macrae
authors.forename: David
authors.initials: D
authors.lastname: Field
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Mercier
authors.forename: Jens
authors.initials: J
authors.lastname: Møller
authors.forename: Tom
authors.initials: T
authors.lastname: Stiris
authors.forename: Paolo
authors.initials: P
authors.lastname: Biban
authors.forename: Paul
authors.initials: P
authors.lastname: Cornick
authors.forename: Allan
authors.initials: A
authors.lastname: Goldman
authors.forename: Sylvia
authors.initials: S
authors.lastname: Göthberg
authors.forename: Lars E
authors.initials: LE
authors.lastname: Gustafsson
authors.forename: Jürg
authors.initials: J
authors.lastname: Hammer
authors.forename: Per-Arne
authors.initials: PA
authors.lastname: Lönnqvist
authors.forename: Manuel
authors.initials: M
authors.lastname: Sanchez-Luna
authors.forename: Gunnar
authors.initials: G
authors.lastname: Sedin
authors.forename: Nim
authors.initials: N
authors.lastname: Subhedar
mesh_terms: D000280:Administration, Inhalation; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D009569:Nitric Oxide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D001993:Bronchodilator Agents; D009569:Nitric Oxide